Overall, patients with germline RET variants significantly differed from those testing negative by the presence of family history (68.2% vs. 2.1%; p < 0.001) and by mean age at MTC diagnosis (44.45 vs. 56.42; p = 0.010). This evidence concerns the gene RET and medullary thyroid gland carcinoma.